Journal issues > Issue 1, February 2022 > Highlights in transplantation

Highlights in transplantation

SUMMARY

Allogeneic haematopoietic cell transplantation (alloHCT) is a complex procedure that involves many different factors: patient characteristics, disease characteristics, donor choice, stem cell source, choice of conditioning regimen, graft versus host disease (GvHD) prevention and treatment, prevention and treatment of disease relapse and management of (non-)infectious complications. This paper discusses some key studies that were presented regarding patient characteristics, donor choice, GvHD prophylaxis and treatment and treatment of disease relapse after alloHCT. Now two years into the pandemic, it is impossible to ignore SARS-CoV-2, seroconversion after mRNA vaccination of alloHCT recipients in France will be discussed.

(BELG J HEMATOL 2022;13(1):43-7)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top